Looking Into Patient Perspectives on Ocular Gene Therapy

Time: 12:25 pm
day: Day One Track B - Morning

Details:

  • Development and validation of the Attitudes to Gene Therapy – Eye (AGT-EYE) tool
  • Results of an Australian national survey of almost 700 people with IRDs and/or their carers on the knowledge and
    perspectives on gene therapy
  • How can academics and industry work more closely with people with IRDs to codesign research and clinical trials?

Speakers: